Paul Rothman

Insider Reports History

Location
Baltimore, MD
Signature
/s/ Kathryn W. Kyle, Attorney-in-Fact for Paul Rothman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul Rothman:

Company Role Class Num Shares Value Price $ Report Date Ownership
Merck & Co., Inc. Director Phantom Stock 31,991 $2,458,173 $76.84 30 May 2025 Direct
LABCORP HOLDINGS INC. Director Common Stock 2,571 $647,403 $251.81 11 Feb 2026 Direct
LABCORP HOLDINGS INC. Director Restricted Stock Unit 773 $220,904 $246.27 11 Feb 2026 Direct
Merck & Co., Inc. Director Common Stock 100 $7,663 $76.63 30 May 2025 Direct

Insider Reports Filed by Paul Rothman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LH LABCORP HOLDINGS INC. 11 Feb 2026 2 $0 4 Director 13 Feb 2026, 13:03
LH LABCORP HOLDINGS INC. 10 Feb 2026 1 $0 4 Director 12 Feb 2026, 11:24
MRK Merck & Co., Inc. 30 May 2025 1 +$220,000 4 Director 03 Jun 2025, 13:18
LH LABCORP HOLDINGS INC. 11 Feb 2025 1 $0 4 Director 13 Feb 2025, 08:26
LH LABCORP HOLDINGS INC. 06 Feb 2025 2 $0 4 Director 10 Feb 2025, 08:38
LH LABCORP HOLDINGS INC. 06 Jun 2024 2 $0 4 Director 10 Jun 2024, 08:52
MRK Merck & Co., Inc. 31 May 2024 1 +$220,000 4 Director 04 Jun 2024, 14:55
LH LABORATORY CORP OF AMERICA HOLDINGS 06 Feb 2024 1 $0 4 Director 08 Feb 2024, 12:53
LH LABORATORY CORP OF AMERICA HOLDINGS 06 Jun 2023 1 $0 4 Director 08 Jun 2023, 08:24
LH LABORATORY CORP OF AMERICA HOLDINGS 06 Jun 2023 0 $0 3 Director 07 Jun 2023, 14:33
MRK Merck & Co., Inc. 26 May 2023 1 +$220,000 4 Director 31 May 2023, 14:50
MRK Merck & Co., Inc. 27 May 2022 1 +$220,000 4 Director 01 Jun 2022, 16:21
MRK Merck & Co., Inc. 28 May 2021 1 +$200,000 4 Director 02 Jun 2021, 13:56